You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone deacetylase gene

Showing 1 - 25 of 6,355
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Relevance of DNMT and HDAC Gene SNP on Response to

Completed
  • Myelodysplastic Syndrome
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Aug 11, 2020

    Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

    Recruiting
    • Heart Failure With Normal Ejection Fraction
    • +3 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 1, 2022

    Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

    Completed
    Has Results
    • Melanoma
    • Skin Cancer
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 18, 2023

    Hodgkin's Lymphoma Trial in Milano (ITF2357)

    Completed
    Has Results
    • Hodgkin's Lymphoma
    • Milano, Italy
      Istituto Nazionale per la Cura e lo Studio dei Tumori
    Apr 20, 2021

    Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

    Recruiting
    • Ototoxicity, Drug-Induced
    • Sodium Thiosulfate
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Mar 6, 2023

    Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

    Terminated
    • Hodgkin's Lymphoma
    • histone deacetylase inhibitor (ITF2357)
    • Milan, Italy
      Istituto Nazionale per lo studio e la cura dei Tumori
    Jan 18, 2022

    Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Perugia, Italy
      Department of Internal Medicine and Public Health, University of
    Jan 18, 2022

    HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

    Active, not recruiting
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +13 more
    Jan 13, 2022

    Safety and Efficacy Trial in Guangzhou, Wuhan (Sintilimab, Chidamide)

    Completed
    • Safety and Efficacy
    • Guangzhou, Guangdong, China
    • +3 more
    Apr 6, 2022

    Multiple Myeloma Trial in Cagliari (ITF2357)

    Terminated
    • Multiple Myeloma
    • Cagliari, Italy
      Presidio Ospedaliero R. Binaghi
    Jan 18, 2022

    Sarcoma Trial in Guangzhou (chidamide and toripalimab)

    Recruiting
    • Sarcoma
    • chidamide and toripalimab
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Univerisity
    Sep 4, 2022

    Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Guangzhou (Toripalimab + Chidamide)

    Recruiting
    • Cervical Cancer
    • +2 more
    • Toripalimab + Chidamide
    • Guangzhou, 广东, China
      Sun Yat-sen University Cancer Centre
    Dec 3, 2020

    Lymphoma, Follicular Trial in China (Abexinostat)

    Recruiting
    • Lymphoma, Follicular
    • Beijing, China
    • +25 more
    Mar 3, 2022

    Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

    Recruiting
    • Peripheral T-cell Lymphoma
    • PD-1 antibody+ HDAC inhibitor
    • Shanghai, Shanghai, China
      Dongmei Ji
    Dec 3, 2021

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    Has Results
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +20 more
    • Scottsdale, Arizona
    • +1 more
    May 6, 2022

    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

    Terminated
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Buffalo, New York
    • +1 more
    Aug 11, 2022

    Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

    Completed
    Has Results
    • Relapsed or Refractory Multiple Myeloma
    • (no location specified)
    Mar 5, 2021

    Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Boston, Massachusetts
    • +4 more
    Feb 7, 2022

    GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)

    Completed
    Has Results
    • Graft Versus Host Disease
    • GVHD
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jul 19, 2021

    Diffuse Large B Cell Lymphoma Trial (Pembrolizumab and CXD101)

    Withdrawn
    • Diffuse Large B Cell Lymphoma
    • Pembrolizumab and CXD101
    • (no location specified)
    Aug 12, 2021

    Renal Cell Carcinoma Trial in United States (LBH589)

    Completed
    Has Results
    • Renal Cell Carcinoma
    • Fort Myers, Florida
    • +9 more
    Oct 26, 2021

    Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

    Active, not recruiting
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Aldesleukin
    • +6 more
    • Los Angeles, California
    • +3 more
    Nov 16, 2022

    Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)

    Terminated
    Has Results
    • Leiomyosarcoma
    • +2 more
    • Vorinostat Oral Capsule
    • Graz, Austria
      Medical University of Graz, Clinic of Obstetrics and Gynecology
    Jul 27, 2020

    APL Trial in Shanghai (Chidamide+venetoclax)

    Active, not recruiting
    • APL
    • Shanghai, Shanghai, China
      Jiong HU
    May 30, 2023

    Angioimmunoblastic T-cell Lymphoma Trial in Guangzhou (Sintilimab, Chidamide)

    Not yet recruiting
    • Angioimmunoblastic T-cell Lymphoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Apr 2, 2021